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Abstract
Background: Early-life chemical exposure may influence immune system development, subsequently affecting child health. We
investigated immunomodulatory potentials of polychlorinated biphenyls (PCBs) and p,p'-DDE in infants.
Methods: Prenatal exposure to PCBs and p,p'-DDE was estimated from maternal serum concentrations during pregnancy.
Postnatal exposure was calculated from concentrations of the compounds in mother's milk, total number of nursing days, and
percentage of full nursing each week during the 3 month nursing period. Number and types of infections among infants were
registered by the mothers (N = 190). White blood cell counts (N = 86) and lymphocyte subsets (N = 52) were analyzed in a
subgroup of infants at 3 months of age.
Results: Infants with the highest prenatal exposure to PCB congeners CB-28, CB-52 and CB-101 had an increased risk of
respiratory infection during the study period. In contrast, the infection odds ratios (ORs) were highest among infants with the
lowest prenatal mono-ortho PCB (CB-105, CB-118, CB-156, CB-167) and di-ortho PCB (CB-138, CB-153, CB-180) exposure,
and postnatal mono- and di-ortho PCB, and p,p'-DDE exposure. Similar results were found for pre- and postnatal CB-153
exposure, a good marker for total PCB exposure. Altogether, a negative relationship was indicated between infections and total
organochlorine compound exposure during the whole pre- and postnatal period. Prenatal exposure to CB-28, CB-52 and CB-
101 was positively associated with numbers of lymphocytes and monocytes in infants 3 months after delivery. Prenatal exposure
to p,p'-DDE was negatively associated with the percentage of eosinophils. No significant associations were found between PCB
and p,p'-DDE exposure and numbers/percentages of lymphocyte subsets, after adjustment for potential confounders.
Conclusion: This hypothesis generating study suggests that background exposure to PCBs and p,p'-DDE early in life modulate
immune system development. Strong correlations between mono- and di-ortho PCBs, and p,p'-DDE exposures make it difficult
to identify the most important contributor to the suggested immunomodulation, and to separate effects due to pre- and
postnatal exposure. The suggested PCB and p,p'-DDE modulation of infection risks may have consequences for the health
development during childhood, since respiratory infections early in life may be risk factors for asthma and middle ear infections.
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Persistent and lipophilic organochlorine compounds,
such as the industrial chemicals polychlorinated biphe-
nyls (PCBs), the pesticide DDT, and dioxin-like contami-
nants polychlorinated dibenzo-p-dioxins (PCDDs) and
dibenzofurans (PCDFs), are immunotoxic to animals and
humans [1-7]. Suppression of the humoral and cellular
immune system is one of the most sensitive endpoints
after prenatal exposure of animals to the highly toxic
dioxin-like compound 2,3,7,8-tetrachloro dibenzo-p-
dioxin (TCDD) [6,7]. Children from Taiwan, who were
accidentally exposed to high levels of both non-dioxin-
like and dioxin like PCBs and polychlorinated dibenzo-
furans (PCDFs) prenatally, had higher rates of bronchitis,
upper respiratory infections and middle ear infections
than normally found in reference populations with low
exposure [4,5].
A few studies have reported that exposures of the fetus
and/or infant to background levels of non-dioxin-like and
dioxin-like PCBs, the DDT metabolite p,p'-DDE, and
PCDD/Fs are associated with alterations in markers of
immune function, such as white blood cell (WBC) counts
and numbers of lymphocyte subsets during childhood [8-
13]. Diverging results have however been reported. On
one hand no associations were found between WBC/lym-
phocyte subset counts and early life exposure to PCBs
among Inuit infants [13]. On the other hand, among
Dutch infants negative associations were found between
monocyte counts and PCB exposure, and positive associ-
ations between CD8+ cytotoxic T-cells and PCB exposure
[12].
High prenatal PCB exposure has been associated with a
decreased thymus size among neonates born in an area
with high environmental load of both non-dioxin-like
and dioxin-like PCBs in Eastern Slovakia [14]. Moreover,
PCB exposure early in life has been found to be positively
associated with acute otitis media and negatively associated
with incidence of asthma or allergies later in life in chil-
dren [10,11,15]. Studies of preschool and school children
have also suggested that exposure to p,p'-DDE early in life
may be a risk factor for acute otitis media and asthma later
during childhood [13,16,17]. A decreased antibody
response after tetanus and diphtheria vaccination was
found among children exposed to high levels of PCBs
early in life [18].
In order to better understand how PCB compounds and
p,p'-DDE may influence children health, we studied the
associations between pre- and postnatal PCB and p,p'-
DDE exposure and numbers and percentages of WBCs
and lymphocyte subsets in three month old infants. More-
over, associations between organochlorine compound
exposure and upper/lower respiratory infections in
infants were studied during the first three months of life.
Compounds were assigned to one of four compound
groups depending on biological activity and sources of
exposure: non-dioxin-like tri- to pentachlorinated PCBs
(CB-28, CB-52 and CB-101), non-dioxin-like di-ortho
PCBs (CB-138, CB-153 and CB-180), dioxin-like mono-
ortho PCBs (CB-105, CB-118, CB-156 and CB-167), and
p,p'-DDE. Exposure to the di-ortho PCB congener CB-153
was used as a marker of total PCB exposure.
Methods
Study population and sampling
Between 1996 and 1999, 325 primiparous women, living
and seeking prenatal care in Uppsala County, Sweden,
agreed to donate a serum sample (82% participation rate)
in late pregnancy (week 32–34) for chemical analysis of
organochlorines [19]. PCB and DDE concentrations in
serum lipids from this sampling were used as an estimate
of prenatal PCB and DDE exposure of the infants, and 190
mother/child pairs had complete data for statistical anal-
yses of associations between prenatal PCB and DDE expo-
sure and diseases among the infants (Table 1).
During the third week after delivery mothers from the
group of 190 participants sampled milk while nursing
their infants, using a manual breast pump and/or a pas-
sive mother's milk sampler [20]. The results of the PCB
and DDE analyses of mother's milk was used in the assess-
ment of postnatal exposure (see below) and 175 mother/
infant pairs had complete data for statistical analyses of
associations between postnatal PCB and DDE exposure
and risk of infections.
Blood was sampled from infants 3 months after delivery
for analysis of numbers and percentages of WBCs and
lymphocyte subsets. The age of 3 months was chosen in
order to facilitate comparison with other studies of immu-
nomodulatory effects of early life PCB and DDE exposure
[11,13]. Moreover, the majority of the infants in Sweden
have mothers'milk as the only source of nutrition during
the first 3 months of life, making confounding of results
due to differences in sources of nutrition less pronounced.
All the 325 mothers, donating blood in late pregnancy,
were asked if they were willing to donate an infant blood
sample after birth. Blood sampling could however not be
continued during the whole study due to lack of financial
resources. Therefore infants of mothers accepting blood
sampling were sampled until 90 infants had been sam-
pled. At that time point 277 mothers had been asked to
donate a blood sample from their infants and the partici-
pation rate in the blood sampling of the infants was thus
32%. Among the 90 mother/infants pairs, data on num-
bers of WBCs were finally available from 81 infants and
percentage data from 85 infants. Lymphocyte subsets
could only be analyzed in 52 infants from this subgroupPage 2 of 14
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Among the infants with data on lymphocyte subsets, data
on lymphocyte numbers and percentages were available
for 47 and 52 infants, respectively. The study was
approved by the Ethics Committee of the Medical Faculty
at Uppsala University. All participating women gave their
informed consent prior to the inclusion in the study
group.
Interviews and questionnaires
At 6–12 and 32–34 completed gestational weeks, in-per-
son interviews regarding maternal characteristics were
performed, using a structured questionnaire [19,21]. Data
on maternal characteristics included age, height, body
weight before pregnancy, body weight at interview, years
of education, and alcohol consumption and smoking
before and during pregnancy. Blood samples for cotinine
analysis (used as indicator of smoking habits) were taken
at both interview occasions.
After delivery, the mothers were visited by a midwife
when the infant was 3 months old. In an in-person inter-
view, using a structured questionnaire, the mothers
answered questions about sex of the infant, vaccination,
nursing habits, and infant health during the first 3
months. Women gave information about the extent of
nursing for each week of the 3 month period (full nursing,
partial nursing and no nursing). The participants also gave
information about the health of the children each week
from delivery to the date of the interview. It was asked if
the infant had any infection or other disease during the 3
month period. If the answer was yes, the mother was
asked to give information about type of disease (open
ended question). The mother was asked to identify the
week/weeks the infant had the disease in an almanac, and
to give the number of days the symptoms lasted. It was
also asked if the infant had a fever during these days, and
number of days with a temperature above 39°C. Finally it
was asked if the symptoms were treated by a physician
and what type of treatment that was used. The interviewer
and the mothers were blinded to the organochlorine com-
pound body burdens of the mother.
Organochlorine compound analysis
The lipid portion of serum samples was analyzed for the
DDT metabolite p,p'-DDE, and 10 PCB congeners (IUPAC
nos. 28, 52, 101, 105, 118, 138, 153, 156, 167 and 180).
The analytical results were consequently lipid adjusted.
Procedures for extraction, sample clean-up and analysis,
and quality control are described in Glynn et al. [19]. In
mother's milk the compounds were analyzed using a
method and quality assurance described by Glynn et al.
[20]. When concentrations were below the limit of quan-
tification (LOQ) they were set to 50% of LOQ in the sta-
tistical analysis.
Immune cell analysis
The hematological tests were performed at the Depart-
ment of Clinical Chemistry, University Hospital of Upp-
sala. Capillary blood samples were collected in
microtainer tubes (Sarstedt, Sweden). Differential counts
were carried out by an automated instrument, Celldyn
4000 (Abbott Scandinavia AB, Solna, Sweden) based on a
combination of optical characteristics and histochemical
reactions. Number of total WBCs, and number and per-
centages of neutrophils, eosinophils, lymphocytes, and
monocytes were recorded.
Analysis of lymphocyte subpopulations was performed
on mononuclear cells prepared by Ficoll-Paque centrifu-
Table 1: Characteristics of the participating mother/child pairsa
Study groups
Variable Infections (N = 190) White blood cells (N = 86) Lymphocyte subsets (N = 52)
Mother's age (yr) 28 (21–41) 29 (21–36) 29 (22–35)
Infant's age (d) 92 (75–123) 93 (76–112) 93 (76–112)
Percent Percent Percent
School yrs ≤ 13:50 14–16:24 >16:26 ≤ 13:50 14–16:27 >16:23 ≤ 13:43 14–16:30 >16:27
Smokingb No:82 Yes:18 No:86 Yes:14 No:89 Yes:11
Alcoholb No:82 Yes:18 No:83 Yes:17 No:77 Yes:23
Nursingc Whole:81 Partial:19 Whole:84 Partial:16 Whole:91 Partial:9
Infant's sex Girl:44 Boy:56 Girl:58 Boy:42 Girl:57 Boy:43
Vaccination No:69 Yes:31 No:76 Yes:24 No:85 Yes:15
Resp. infection No:72 Yes:28 No:71 Yes:29 No:78 Yes:22
aMother's and infant's age: median (range). WBCs were analyzed in a subgroup of 86 infants, and within this subgroup lymphocyte subsets were 
analyzed among 52 infants with enough blood left after WBC count analysis.
bDuring pregnancy. 
cPartial nursing also includes no nursing.Page 3 of 14
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following subpopulations were evaluated by flow cytom-
etry: CD3+ cells (T-lymphocytes), CD19+ cells (B-lym-
phocytes), CD4+ cells (T-helper cells), CD8+ cells
(cytotoxic cells), and CD56+ cells (NK-cells).
Calculations and statistics
Lipid-adjusted serum organochlorine compound concen-
trations among the mothers in late pregnancy were used
as a measure of prenatal exposure of the fetus [23-25].
Postnatal exposure (PE) (ng or pg/g*days) was calculated
from the organochlorine concentration (ng or pg/g fresh
weight) in mother's milk three weeks after delivery
(Oconc), the number of days of nursing (Nd), and the
percentage of full nursing during the study period (%N)
using the equation
PE (ng or pg/g*days) = Oconc*Nd*(%N/100).
For women who did not nurse their infants PE = 0. The
nursed infant's cumulative intake of organochlorine com-
pounds is the product of the concentration of the organo-
chlorine compound in question in the mothers' milk (per
gram fresh weight), the amount of milk consumed per day
(in grams), and the number of days of nursing [26,27].
We did not have information about the amount of milk
consumed by the infants. Instead we had information
about the degree of nursing each week (full, partial or
none). Consequently, the degree of nursing was used
instead of the amount of mothers' milk consumed in the
intake calculation.
In the exposure analysis, tri- to penta-chlorinated CB-28,
CB-52 and CB-101, with no dioxin-like biological activity,
were grouped together (CB 28+52+101) because serum
levels of these compounds showed low correlations with
serum levels of the other organochlorine compounds
(Spearman's r = 0.13–0.24). These three congeners have
been detected in elevated levels in indoor air of buildings
containing PCB-laden building materials and in the blood
of residents of such buildings [28-31]. CB-138, CB-153
and CB-180 (di-ortho PCBs) were grouped together
because of high correlations between mother's serum con-
centrations of these congeners (r > 0.90), and because of
their lack of dioxin-like biological activity [32]. Dioxin-
like mono-ortho PCBs consisted of CB-105, CB-118, CB-
156 and CB-167 [32]. p,p'-DDE was treated separately in
the statistical analysis. In order to improve the possibili-
ties to compare our PCB results with those of other similar
studies, statistical analysis was also performed using expo-
sure to the di-ortho PCB congener CB-153 as independent
exposure variable. Concentrations of CB-153 in blood
serum of the mothers was highly correlated with concen-
trations of total PCB (Spearman's r = 0.97), showing that
CB-153 exposure is a good marker of total PCB exposure.
Exposure to dioxin-like mono-ortho PCBs were summa-
rized using WHO 1998 toxic equivalency factors (TEFs)
for the congeners CB-105 (TEF = 0.0001), CB-118
(0.0001), CB-156 (0.0005), and CB-167 (0.00001) [32].
The concentration of the individual congeners was multi-
plied with the TEF of the congener in question [32], and
the resulting concentration of toxicity equivalents (TEQs)
for each congener was then summarized in to a sum of
mono-ortho TEQ concentration for each sample.
Statistical analysis was performed using MINITAB® For
Windows, 14. Spearman's rank correlation analysis was
used in analysis of correlations between different expo-
sure variables. The associations between immune cell
numbers/percentages and organochlorine compound
exposure were explored by linear regression analysis. Six
infants had an ongoing infection at the time of sampling,
or an infection within a period of 7 days before the sam-
pling day. These infants were not included in the statisti-
cal analyses. Regression analysis was performed on
logarithmically transformed organochlorine compound
exposure data, since the distributions of data closely fol-
lowed a log-normal distribution. However, in the case of
prenatal exposure to CB 28+52+101 many women had
serum levels below LOQ and this exposure variable was
therefore categorized. Some women did not nurse their
infants at all, and postnatal exposure of these infants was
set to zero. This made logarithmic transformation impos-
sible and postnatal exposure was therefore categorized.
Prenatal CB 28+52+101 exposure was categorized in 3 cat-
egories. The study participants could not be categorized in
tertiles since over 40% had concentrations below the
LOQ. Mother/infants pairs with CB 28+52+101 concen-
trations below the LOQ were grouped in the reference cat-
egory and the rest of the study participants divided up in
equal numbers in the two other categories depending on
exposure levels. Postnatal organochlorine compound
exposure was categorized in tertiles when possible, other-
wise an effort was made to have equal numbers of study
participants in each of the three exposure categories.
In the statistical analysis of immune cell results the signif-
icance level was set to p ≤ 0.01, since multiple compari-
sons were made. In cases when a statistically significant
association between immune cells and organochlorine
compound exposure was found in simple regression anal-
ysis, multiple regression analysis was used to adjust the
associations for potential confounders. We included life-
style/medical factors in the multiple regression analyses
that have previously been reported to be associated with
increased or decreased risk of immune-related diseases
[33-38]. Potential confounders included in the analysis
were age of the mother, smoking during pregnancy (non-
smoker/former smoker/smoked during pregnancy), alco-
hol consumption during pregnancy (no/yes), mother'sPage 4 of 14
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tion/>16 years of eduction), vaccination status of the
infant at the time of sampling (no/yes), nursing of the
infant (no or partial nursing/full nursing), age of the
infant, and infant's past history of respiratory infections
during the study period (up to 7 days before sampling,
no/yes). In linear regression analysis a few observations
with a standardized residual ≥ 3.0 were omitted from the
data sets due to a large impact on the regression results.
In the analysis of infection results (no/yes), odds ratios
(ORs) and 95% confidence intervals (CIs) were calculated
using logistic regression. Respiratory infection (influenza-
like symptoms, common cold, or common cold with
cough) (N = 54) was the only health problem that was fre-
quent enough to allow statistical analysis. Other health
problems reported were stomach problems (N = 1), navel
infection (N = 1), cows' milk intolerance/allergy (N = 1),
urinary infection (N = 1), eye infection (N = 2) and mid-
dle ear infection (N = 2). In the logistic regression analysis
all independent variables were categorized in order to
handle outlier problems. First, ORs were calculated in
regressions with the exposure to each organochlorine
compound group as the only independent variable. In the
next step the ORs were adjusted for the same possible con-
founders as in the analyses of immune cell counts/per-
centages (except infant's history of infection, see above).
A stricter definition of respiratory infection was also used
(three days or more of infection, N = 50) in the statistical
analysis. The information about number of infections
during the study period could not be used in the statistical
analyses of the results, since only 7 infants had more than
one infection during the study period. Similarly, too few
infants had been examined by a physician. It was not pos-
sible to use the information about infection in combina-
tion with information about body temperature in the
statistical analysis, since there were too many missing val-
ues for the latter variable.
We also analyzed the associations between respiratory
infections and the total exposure to PCBs and p,p'-DDE
during the whole prenatal and postnatal period. This
analysis was based on a summation of each infant's cate-
gorized pre-and postnatal exposure to all compound
groups. We did not calculate a sum of the absolute con-
centrations since such a summation assumes equal immu-
nomodulatory potency of all the studied compounds. For
example, when absolute concentrations are summed up,
effects of relatively potent compounds present at low con-
centrations may be underestimated, and effects of less
potent compounds present at high concentrations overes-
timated. We avoided this by summing up exposure scores
for each compound group. First each infant's pre- and
postnatal PCB and p,p'-DDE exposures were separately
scored, with the lowest score 1 given to the lowest expo-
sure quartile and the highest score 4 given to the highest
exposure quartile (scores 1–3 for prenatal CB 28+52+101
exposure). The scores for pre- and postnatal exposures
were then summarized for each compound group. For
example, if an infant scored 1 for prenatal exposure to p,p'-
DDE and scored 3 for postnatal p,p'-DDE exposure then
the infant was assigned a score of 4 in the summation of
pre- and postnatal p,p'-DDE exposure. The resulting sum
of the pre-and postnatal exposure scores of each com-
pound group was then added to get the total exposure
score. In this case, if an infant had scored 5 for total CB
28+52+101 exposure, 8 for mono-ortho PCB exposure, 6
for di-ortho PCB exposure, and 5 for p,p'-DDE exposure,
the total organochlorine compound exposure score was
summed up to 24. The total exposure scores were subse-
quently divided into quartiles in the final statistical anal-
yses of associations between infections and total
organochlorine exposure. The level of statistical signifi-
cance in logistic regression analysis was set to p ≤ 0.05.
Results
Personal characteristics
Table 1 gives the personal characteristics of the whole
study group (infection), the subgroup of mother/infant
pairs that donated blood for WBC counts, and mother/
infant pairs within this subgroup that donated enough
blood for lymphocyte subset analyses. A comparison of
personal characteristics between the study participants
that did not donate infant blood (N = 104) with those
donating infant blood (N = 86) showed no significant dif-
ferences in age of the mothers and infants (t-test, p = 0.29
and p = 0.82) (Table 1). No difference was found between
the two subgroups in smoking during pregnancy (Chi-
square test, p = 0.064), alcohol consumption during preg-
nancy (Chi-square test, p = 0.89), years of education (Chi-
square test, p = 0.57), nursing (Chi-square test, p = 0.28),
and respiratory infections (Chi-square test, p = 0.52). Fur-
thermore, pre- and postnatal organochlorine compound
exposure did not differ between the groups (t-test, p =
0.054–0.84). However, there were more girls than boys in
the subgroup with blood samples, whereas the reverse was
evident among mother/infant pairs that did not donate
infant blood (Chi-square test, p = 0.002). Fewer had been
vaccinated at the end of the study period among infants
with blood samples (Chi-square test, p = 0.038).
Pre- and postnatal exposure
The median prenatal exposure of the sum of CB-28, CB-52
and CB-101 was low (Table 2). Over 40% of the mothers
in the whole study group had concentrations of all the
three substances in serum lipids below the LOQ. Concen-
trations ≥ 10 ng/g lipid were however found in 15% of the
study participants. Median concentrations of di-ortho
PCBs (CB-138, CB-153 and CB-180) and p,p'-DDE werePage 5 of 14
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concentrations of mono-ortho PCB TEQs varied 9-fold or
more (Table 2).
Correlations between serum concentrations of CB
28+52+101 and the other organochlorines in the total
study group (infection) were weak, with Spearman corre-
lation coefficients ranging from 0.13 to 0.24. Concentra-
tions of CB-153, di-ortho PCBs and mono-ortho PCB TEQs
were strongly correlated (r ≥ 0.93), whereas correlations
between these PCBs and p,p'-DDE were less strong (r =
0.66–0.75).
Variation in organochlorine exposure from mother's milk
during the first 3 months of infancy was large (Table 2).
The correlation between postnatal exposure to CB-153,
di-ortho PCBs and mono-ortho TEQs was strong (r ≥ 0.93).
Other correlations between the studied compound groups
were less strong (r = 0.40–0.82). Pre- and postnatal expo-
sure of each compound group was significantly correlated,
ranging from r = 0.71 to r = 0.78.
Organochlorine compound exposure and WBCs
The numbers and percentages of WBCs are presented in
Table 3. In both simple and multivariate regression anal-
Table 2: Organochlorine concentrations in mother's serum lipids in late pregnancy and infant exposure from mother's milka
Exposure Study groups
Serumb Infections White blood cells Lymphocyte subsets
CB 28+52+101 4 (3–427) 4 (3–427) 4 (3–19)
CB-153 60 (23–179) 57 (23–158) 59 (23–158)
Di-ortho PCB 131 (44–362) 127 (44–342) 129 (44–342)
Mono-ortho PCB TEQ 4 (1–20) 4 (1–11) 4 (1–9)
p,p'-DDE 88 (21–622) 85 (24–622) 83 (29–622)
Mother's milk exposurec
CB 28+52+101 8 (0–155) 8 (0–76) 9 (0–39)
CB-153 187 (0–853) 174 (0–396) 186 (0–396)
Di-ortho PCB 364 (0–1666) 351 (0–830) 372 (0–830)
Mono-ortho PCB TEQ 11 (0–54) 11 (0–26) 11 (0–26)
p,p'-DDE 311 (0–2199) 289 (0–2199) 306 (0–2199)
aMedian (range). Di-ortho PCB = CB-138, CB-153, CB-180; Mono-ortho PCB TEQ = CB-105, CB-118, CB-156, CB-167 [32]. The study group 
"Infections" consists of all study participants (prenatal exposure N = 190; postnatal exposure N = 175), the "White blood cells" group is a subgroup 
of infants among the study participants which had their WBC counts analyzed (N = 86), and within this subgroup lymphocyte subsets were analyzed 
in the "Lymphocyte" group composed of infants with enough blood left after WBC count analysis (N = 52).
bng/g lipid. Mono-ortho PCBs: pg TEQ/g lipid [32]. Serum sampled week 32–34.
cng/g fresh weight*days. Mono-ortho PCBs: pg TEQ/g fresh weight*days. Calculated as organochlorine concentration in mother's milk on a fresh 
weight basis*days of nursing*(%of full nursing/100).
Table 3: Numbers and percentages of white blood cells (WBC) and lymphocyte subsets in 3 month old infantsa
Differential count N No. of cells × 109/L N % of WBC
White blood cells 81 8 (5–15)
Neutrophils 80 1.6 (0.6–5.7) 85 21 (8–47)
Eosinophils 80 0.3 (0.1–1.0) 85 4 (0.5–10)
Lymphocytes 80 5.4 (2.9–9.5) 85 70 (37–86)
Monocytes 80 0.3 (0.1–1.4) 85 4 (1–15)
Lymphocyte subsets % of lymphocytes
CD19+ 47 0.8 (0.1–2.0) 51 16 (2–34)
CD3+ 47 3.7 (1.5–7.3) 52 70 (38–85)
CD4+CD8- 47 3.1 (1.0–5.3) 52 55 (24–72)
CD4-CD8+ 47 0.7 (0.2–2.1) 52 13 (5–23)
CD56+ 47 0.05 (0–0.1) 52 0.8 (0–2.2)
aMedian (range)Page 6 of 14
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significantly higher mean numbers of total WBCs, lym-
phocytes and monocytes than infants in the reference cat-
egory with the lowest exposure (Figure 1). The percentage
of eosinophils was negatively associated with prenatal
p,p'-DDE exposure (Table 4). Otherwise, no significant
associations between prenatal exposure and WBC counts/
percentages were found (Figure 1, Table 4).
Numbers and percentages of WBCs were not significantly
associated with postnatal exposure to any of the analyzed
organochlorines, except for a higher percentage of lym-
phocytes among infant with the highest post-natal p,p'-
DDE exposure in the univariate analysis (see Additional
file 1 and Additional file 2).
Organochlorine exposure and lymphocyte subsets
We found a statistically significant negative association
between percentage of CD4-CD8+ cells and prenatal expo-
sure to CB-153, di-ortho and mono-ortho PCBs in the uni-
variate analysis (Table 4). After adjustment for potential
confounders the associations were not statistically signifi-
cant. In other cases, numbers and percentages of different
lymphocyte subsets were not associated with prenatal
exposure (Figure 2, Table 4). Postnatal exposure of the
infants to the organochlorines was not significantly asso-
ciated with numbers and percentages of lymphocyte sub-
sets, except for a significantly higher number and
percentage of CD56+ among infants in the second highest
exposure group of post-natal CB-153 exposure (see Addi-
tional file 3 and Additional file 4).
Respiratory infections
Infants with the highest prenatal CB 28+52+101 exposure
had a significantly increased odds ratio for respiratory
infections during the first three months after birth com-
pared with the lowest exposed infants (Table 5). This find-
ing did not change in multivariate-adjusted logistic
regression analysis. Moreover, a lowered odds ratio was
found for infants in the second to fourth exposure cate-
gory of prenatal di-ortho PCB exposure, although the dif-
ference between the highest exposure category and the
reference category only showed borderline statistical sig-
nificance (Table 5). Similar results were found for prena-
tal CB-153 exposure. A lowered odds ratio was also found
for infants in the highest exposure category of prenatal
Table 4: Regression coefficients for associations between organochlorine exposure prenatally and numbers and percentages of white 
blood cells and lymphocyte subsetsa
CB 153 Di-ortho PCB Mono-ortho PCB TEQ p,p'-DDE
White blood cell countb 0.01 ± 0.52 0.04 ± 0.54 0.31 ± 0.45 0.46 ± 0.36
Neutrophil numbersb 0.04 ± 0.18 0.05 ± 0.18 0.08 ± 0.15 -0.03 ± 0.12
Neutrophil %b 1.11 ± 2.27 1.09 ± 2.23 0.36 ± 1.85 -0.80 ± 1.51
Eosinophil numbersb -0.00 ± 0.04 0.001 ± 0.04 0.01 ± 0.03 -0.06 ± 0.03
Eosinophil %b 0.05 ± 0.57 0.02 ± 0.59 0.002 ± 0.49 -1.06 ± 0.38*
Eosinophil %c -1.62 ± 0.46*
Lymphocyte numbersb -0.03 ± 0.41 -0.01 ± 0.43 0.17 ± 0.35 0.48 ± 0.28
Lymphocyte %b -1.05 ± 2.31 -1.07 ± 2.39 0.06 ± 1.99 1.41 ± 1.61
Monocyte numbersb 0.004 ± 0.05 0.01 ± 0.05 -0.01 ± 0.04 0.04 ± 0.03
Monocyte %b 0.24 ± 0.51 0.32 ± 0.53 -0.15 ± 0.44 0.36 ± 0.36
CD19+ numbersb -0.07 ± 0.16 -0.06 ± 0.16 -0.07 ± 0.15 0.03 ± 0.11
CD19+ %b -0.41 ± 2.55 0.05 ± 2.6 0.87 ± 2.3 -0.81 ± 1.7
CD3+ numbersb -0.08 ± 0.46 -0.05 ± 0.47 -0.19 ± 0.42 0.42 ± 0.30
CD3+ %b -3.33 ± 4.09 -2.9 ± 4.2 -3.1 ± 3.8 -0.89 ± 2.8
CD4+CD8- numbersb 0.04 ± 0.36 0.13 ± 0.37 0.05 ± 0.33 0.29 ± 0.24
CD4+CD8- %b -0.18 ± 3.89 0.17 ± 4.02 0.03 ± 3.68 -0.63 ± 2.70
CD4-CD8+ numbersb -0.22 ± 0.08 -0.24 ± 0.09 -0.19 ± 0.08 -0.15 ± 0.06
CD4-CD8+ %b -3.54 ± 1.19* -3.84 ± 1.23* -3.28 ± 1.12* -1.98 ± 0.92
CD4-CD8+ %c -3.69 ± 1.93 -4.08 ± 2.05 -4.91 ± 2.05
CD56+ numbersb 0.01 ± 0.01 0.01 ± 0.01 0.003 ± 0.009 0.003 ± 0.007
CD56+ %b 0.27 ± 0.18 0.24 ± 0.19 0.18 ± 0.17 0.07 ± 0.13
aInfants with an ongoing infection at the time of sampling were excluded, as well as infants that had an infection within 7 days before sampling. 
Prenatal exposure: lipid adjusted mother's serum organochlorine compound concentrations in late pregnancy (week 32–34). Di-ortho PCB = CB-
138, CB-153, CB-180; Mono-ortho PCB TEQ = CB-105, CB-118, CB-156, CB-167 [32]. White blood cell counts: N = 75–79. Lymphocyte subsets: 
N = 45–50.
bRegression coefficients from simple regression analysis (mean ± SE)
cPartial regression coefficients (mean ± SE) adjusted for age of the mother, smoking and alcohol during pregnancy, mother's education, vaccination 
of the infant, nursing of the infant, age of the infant, and infant's history of respiratory infections.
*p ≤ 0.01.Page 7 of 14
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analysis (Table 5). Infants with the lowest prenatal p,p'-
DDE exposure had a higher odds ratio than infants with
higher p,p'-DDE exposures, but the difference never
reached statistical significance. Similar results were evi-
dent when a stricter definition of respiratory infection (3
days or more of infection) was used (Additional file 5).
In the analysis of postnatal exposure, the OR for respira-
tory infections among infants in the highest exposure cat-
egory of CB-153 and di-ortho PCB exposure was
significantly lower than that of the reference category in
the unadjusted analysis (Table 5). Multivariate analysis
did not change this difference markedly. Significantly
lowered ORs were observed for the second exposure cate-
White blood cells (WBC) and prenatal exposure to PCB congeners CB-28, CB-52 and CB-101Figure 1
White blood cells (WBC) and prenatal exposure to PCB congeners CB-28, CB-52 and CB-101. Unadjusted and 
adjusted means (± SE) of WBC numbers and percentages in three months old infants prenatally exposed to the sum of CB-28, 
CB-52 and CB-101. Lipid adjusted serum concentrations of the PCB compounds in the blood of the mothers in late pregnancy 
(week 32–34) were used as a measure of prenatal exposure. Infants having an infection within a 7 day period before sampling 
were excluded from the statistical analyses. Adjusted means were calculated in cases when statistically significant results were 
found in the unadjusted analysis. Results were adjusted for age of the mother, smoking and alcohol during pregnancy, mother's 
education, vaccination of the infant, nursing of the infant, age of the infant, and infant's history of respiratory infections. The 
exposure variable was categorized since over 40% of the mothers had serum lipid levels of the PCBs below the limit of quanti-
fication (reference category 1). An effort was made to have equal numbers of participants in the two other exposure catego-
ries. *Significantly different from the group with the lowest exposure (reference category 1) (N = 75–79, p ≤ 0.01).Page 8 of 14
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shaped relationship (Table 5). An U-shaped relationship
was also suggested for CB 28+52+101, but the differences
in odds ratio between the reference category and the other
exposure categories were not statistically significant. Sim-
ilar results were found when a stricter definition of respi-
ratory infection was used (infection for 3 or more days)
was used in the statistical analyses (Additional file 5).
ORs for respiratory infections among infants in the sec-
ond, third and fourth categories of total organochlorine
compound exposure during the whole pre- and postnatal
period were 0.74 (95% confidence interval:0.29–1.88),
0.36 (0.13–0.96), and 0.68 (0.28–1.68), respectively.
Discussion
In this exploratory study of associations between early life
exposure to organochlorine compounds and risks of res-
piratory infections among 3 month old infants, diverging
associations between exposure to organochlorines com-
pounds and infection risk were found. Our results suggest
that high prenatal background exposure to the PCB con-
geners CB-28, CB-52 and CB-101 may increase the risk of
respiratory infections among infants. The reverse was sug-
gested among infants with high background exposure to
mono- and di-ortho PCBs prenatally, and high mono- and
di-ortho PCB and p,p'-DDE exposure postnatally, although
the dose-response in some cases was not monotonic. Sim-
ilar results were found for the single di-ortho congener CB-
153, which is a good marker for total PCB exposure. The
strong correlations between dioxin-like mono-ortho PCB,
non-dioxin-like di-ortho PCB (including CB-153), and
p,p'-DDE exposures among the Uppsala infants make it
difficult to suggest which of the organochlorine com-
pound groups that contributes most to the observed
decline in infection risk at higher exposures. Another
complicating factor is that body burdens of PCDD/Fs are
strongly correlated with body burdens of mono- and di-
ortho PCBs among the Uppsala mothers [20], making it
even more difficult to draw conclusions about the contri-
bution of non-dioxin-like and dioxin-like compounds to
the suggested effects.
We did not study mechanisms behind the PCB and p,p'-
DDE modulation of infection risks, and the study was not
designed to study immunoactivation or -suppression. It
may however be speculated that low-dose dioxin-like
effects could be involved in the seemingly protective effect
of the strongly correlated mono- and di-ortho PCBs, and
p,p'-DDE. Studies of TCDD-exposed rodents have indi-
cated that parts of the immune system may be activated at
low exposure levels and suppressed at higher exposures
[39-41]. Moreover, pre- and postnatal exposure of rats to
low doses of TCDD enhanced innate immune response to
Lymphocyte subsets and prenatal exposure to the PCB congeners CB-28, CB-52 and CB-101Figure 2
Lymphocyte subsets and prenatal exposure to the PCB congeners CB-28, CB-52 and CB-101. Unadjusted means 
(± SE) of numbers and percentages of lymphocyte subsets in three months old infants prenatally exposed to the sum of CB-28, 
CB-52 and CB-101. Lipid-adjusted serum concentrations of the PCB compounds in the blood of the mothers in late pregnancy 
(week 32–34) were used as a measure of prenatal exposure. Infants having an infection within a 7 day period before sampling 
were excluded from the statistical analyses. The exposure variable was categorized since over 40% of the mothers had serum 
lipid levels of the PCBs below the limit of quantification (reference category 1). An effort was made to have equal numbers of 
participants in the two other exposure categories. *Significantly different from the group with the lowest exposure (reference 
category 1) (N = 45–50, p ≤ 0.01).Page 9 of 14
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and increased interferon γ levels in the lungs in both
males and females, and suppressed cell mediated and
antibody responses in females [42,43].
High prenatal CB 28+52+101 exposure increased the
infection risk among the infants. Correlations between
infant exposures to CB 28+52+101 and the other organo-
chlorine compound groups studied by us were weak,
probably due to different sources of exposure. Food is the
major source of mono- and di-ortho PCB and p,p'-DDE
exposure [44]. Our results suggest that food exposure to
CB 28+52+101 generally is low, as indicated by the low
levels of the compounds in serum lipid and mother's milk
among a large part of the mothers. The high body burdens
of CB 28+52+101 among some of the mothers, may be
due to exposure in the in-door environment from PCB-
laden building materials [30]. The associations between
high exposure to CB 28+52+101 and increased risks of
infections could reflect other exposures common for
"PCB-houses". In our cohort, however, no associations
were found between elevated concentrations of these
three PCB congeners in maternal serum and residence
during pregnancy in buildings built during the PCB usage
period (1956–1972) [19]. It can nevertheless not be
excluded that exposure to unknown environmental fac-
tors in PCB buildings contributed to the observed associ-
ations between PCB 28+52+101 exposure and risk of
respiratory infections among the infants. No previous
study has reported associations between infection risks
among infants and pre- and postnatal exposure to CB-28,
CB-52 and CB-101. No difference in health complaints
was observed between children from a CB 28+52+101-
contaminated school and children from a non-contami-
nated school [31].
The congeners CB-28, CB-52, CB-101, as well as the di-
ortho PCBs, are non-dioxin-like PCBs. They may act
through pathways independent of the aryl hydrocarbon
receptor, which binds dioxin-like compounds [45-48].
Little is known about immunotoxic effects of non-dioxin-
like PCB congeners CB-28, CB-52 and CB-101. In contrast
Table 5: Odds ratios (95% CI) for associations between respiratory infection during the first 3 months after birth and pre- or postnatal 
exposure to organochlorine compoundsa
Modelb Exposure categoriesc
Prenatal Category 1 Category 2 Category 3 Category 4
CB 28+52+101 Unadjusted 1.0 1.5 (0.66–3.3) 2.6 (1.2–5.6)*
Multivariate 1.0 1.7 (0.71–4.1) 3.4 (1.4–7.8)*
CB 153 Unadjusted 1.0 0.43 (0.18–1.04) 0.37 (0.15–0.91)* 0.54 (0.23–1.3)
Multivariate 1.0 0.45 (0.17–1.19) 0.30 (0.10–0.88)* 0.42 (0.12–1.4)
Di-ortho PCB Unadjusted 1.0 0.35 (0.14–0.86)* 0.34 (0.14–0.83)* 0.49 (0.21–1.2)
Multivariate 1.0 0.28 (0.10–0.79)* 0.23 (0.07–0.71)* 0.29 (0.08–1.0)
Mono-ortho PCB TEQ Unadjusted 1.0 0.71 (0.30–1.7) 0.54 (0.23–1.3) 0.46 (0.19–1.2)
Multivariate 1.0 0.58 (0.22–1.6) 0.34 (0.10–1.1) 0.23 (0.06–0.91)*
p,p'-DDE Unadjusted 1.0 0.67 (0.27–1.6) 0.73 (0.30–1.78) 0.80 (0.34–1.9)
Multivariate 1.0 0.64 (0.24–1.7) 0.69 (0.25–1.9) 0.74 (0.25–2.2)
Postnatal
CB 28+52+101 Unadjusted 1.0 0.51 (0.19–1.4) 0.72 (0.28–1.9) 1.4 (0.58–3.4)
Multivariate 1.0 0.44 (0.14–1.4) 0.65 (0.23–1.8) 1.4 (0.53–3.8)
CB 153 Unadjusted 1.0 0.55 (0.22–1.4) 0.66 (0.27–1.6) 0.37 (0.14–0.97)*
Multivariate 1.0 0.38 (0.12–1.2) 0.40 (0.13–1.2) 0.20 (0.06–0.73)*
Di-ortho PCB Unadjusted 1.0 0.48 (0.19–1.2) 0.53 (0.21–1.3) 0.31 (0.12–0.83)*
Multivariate 1.0 0.27 (0.08–0.87)* 0.26 (0.08–0.85)* 0.14 (0.04–0.50)*
Mono-ortho PCB TEQ Unadjusted 1.0 0.36 (0.14–0.97)* 0.53 (0.21–1.3) 0.69 (0.29–1.7)
Multivariate 1.0 0.23 (0.07–0.79)* 0.37 (0.12–1.2) 0.33 (0.10–1.1)
p,p'-DDE Unadjusted 1.0 0.25 (0.09–0.71)* 0.53 (0.21–1.3) 0.69 (0.29–1.7)
Multivariate 1.0 0.18 (0.06–0.60)* 0.40 (0.14–1.2) 0.52 (0.17–1.5)
aPrenatal exposure: lipid adjusted mother's serum organochlorine compound concentrations in late pregnancy (week 32–34). Postnatal exposure: 
mother's milk concentrations on a fresh weight basis*days of nursing*(%of full nursing/100). Di-ortho PCB = CB-138, CB-153, CB-180; Mono-ortho 
PCB TEQ = CB-105, CB-118, CB-156, CB-167 [32]. Prenatal exposure:N = 190. Postnatal exposure:N = 175.
bMultivariate model also included the independent variables age of the mother, smoking and alcohol during pregnancy, mother's education, 
vaccination of the infant, nursing of the infant, and age of the infant.
cPre- and postnatal exposure was categorized with the lowest exposure in Category 1 and increasing exposure with increasing Category number. 
Efforts were made to have equal numbers of participants in the exposure categories for each compound group.
*Significantly different from the odds ratio of the reference category (p ≤ 0.05).Page 10 of 14
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induced apoptosis in mice spleen cells in vitro [48]. More-
over, CB-28 and CB-52 caused rapid cell death among rat
thymocytes in vitro, whereas CB-77 did not cause this
effect at the same exposure concentration [49].
Only a few earlier studies have looked at associations
between background PCB and p,p'-DDE exposure early in
life and infant risk of respiratory infections. Among 3–6
months old Dutch and Inuit infants no significant associ-
ations were found between risks of respiratory infections
and pre- or postnatal exposure to the congeners CB-118,
CB-138, CB-153 and CB-180 [12,13,50]. In one of the
Inuit studies a significant positive trend was found
between prenatal PCB exposure and all infections, includ-
ing respiratory and gastrointestinal tract infections and
otitis media [50]. No significant trends of decreased or
increase risk of respiratory infections with increased p,p'-
DDE exposure were found among the Inuit infants
[13,50].
It is difficult to determine the reasons behind the diverg-
ing results between studies. Pre-and postnatal exposure
levels were higher among the Dutch and Inuit infants than
among infants from Uppsala. For instance, the mean level
of the sum of di-ortho congeners CB-138, CB-153 and CB-
180 was 375–620 ng/g lipid in plasma/milk from Dutch
and Inuit mothers (assuming a lipid content of 0.6% of
blood plasma) [12,13], whereas it was 143 ng/g lipid in
blood serum among the Uppsala women. Mean level of
the PCB marker congener CB-153 in cord blood/mother's
plasma lipids in the other Inuit study was 2-fold higher
than the mean level found in mother's serum lipids in the
Uppsala cohort [19,50]. Mean body burdens of p,p'-DDE
among Inuit mothers were 3- to 11-fold higher than
among the Uppsala mothers [13,50]. Moreover, the
results in the Inuit studies may have been influenced by
the general health status of the infants, since acute otitis
media was common among the Inuit infants [13].
Our study is small and the results should therefore be
interpreted with caution. It may have been difficult for
mothers to correctly report infant health history of
infants. Bias could have been introduced in the diagnosis
of disease, since the disease diagnosis was not confirmed
from medical records. The women did not get informa-
tion about their body burdens of organochlorine com-
pounds, avoiding bias in the reporting of diseases due to
knowledge about the degree of exposure of the infant.
Even though the results were adjusted with several poten-
tial confounders, unknown factors may still be involved
in the associations observed. The results therefore have to
be considered as hypothesis generating.
WBC and lymphocyte subset analyses were performed at
the end of the 3 month study period. Therefore some of
the observed associations with organochlorine com-
pound exposure may be a consequence of the respiratory
infections the infants had experienced during the study
period. An increased number of lymphocytes and mono-
cytes, as observed among infants with the highest CB
28+52+101 prenatal exposure, are indicators of infections
and inflammation [51,52]. Therefore increased WBC
counts could be related to more recent infections. How-
ever, infants that had an infection within 7 days before
blood sampling for WBC and lymphocyte subset analyses
were excluded from the statistical analyses. Moreover,
adjustment of the immune cell results for infant's history
of respiratory infections during the study period (yes/no)
did not alter the observed associations. The immune sys-
tem is very complex and we only studied a few immune
markers. It is consequently difficult to draw conclusions
about the relation between immune cell and infection
results. The few observed shifts in immune cell numbers/
percentages associated with organochlorine compound
exposure were generally within the normal range [53,54],
making it difficult to determine the clinical consequences
of the observed shifts.
Prenatal mono- and di-ortho PCBs (including CB-153)
exposures were negatively associated with the percentage
of CD8+ cytotoxic T-cells in the univariate analysis. Both
animal and human studies suggest that early life exposure
to dioxin-like compounds may modulate the numbers/
percentages of CD8+ cytotoxic T-cells. In mice and rat off-
spring, the population of CD8+ cytotoxic T-cells was
increased after pre- and postnatal TCDD exposure
[2,55,56]. Among 18 month old Dutch infants a positive
association was found between CD8+ cell numbers and
prenatal exposure to PCBs and PCDD/Fs in univariate
analyses. No association was however found at 3 months
of age [12]. The Dutch study was smaller than our study,
and the statistically significant associations in the univar-
iate analyses were not adjusted for potential confounders.
In our study the negative associations between mono- and
di-ortho PCB exposures and percentage of CD8+ were not
statistically significant after adjustment for potential con-
founders. Differences in exposure levels of dioxin-like
PCBs and PCDD/Fs also contribute to the difficulties to
compare results between Uppsala (mean:19 pg total TEQ/
g mother's milk lipid) and Dutch infants (64 pg TEQ/g
lipid) [12,20].
We found no indications of influence of pre- and postna-
tal p,p'-DDE exposure on numbers of different types of
lymphocytes, which is in accordance with the results
reported for Inuit infants [13]. A negative association
between prenatal p,p'-DDE exposure and percentage of
eosinophilic granulocytes was however observed among
the Uppsala infants. A study on German children in the
ages 7–10 years reported a reduced eosinophilic granula
content of eosinophilic granulocytes among children withPage 11 of 14
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together the results indicate that eosinophilic granulo-
cytes may respond to background exposures to p,p'-DDE
among infants and children.
The WBC count and the analysis of lymphocyte subsets
were performed on only 50–80 infants, and there were
proportionally more girls in this subgroup than in the
group of mother/infant pairs that did not donate blood.
Moreover, fewer of the infants in the WBC group had been
vaccinated. The immune cell results can therefore not be
directly extrapolated to the whole study group. The
immune cell numbers and percentages were only meas-
ured at one time point at the end of the 3 month study
period, and we do not know if the results are representa-
tive for the other parts of the study period. Many statistical
comparisons were made and it can therefore not be
excluded that the results were due to chance. We used a
strict significance level (p ≤ 0.01) and the results did not
change significantly after adjustment for potential con-
founders, which reduces the possibility of chance find-
ings.
Conclusion
This hypothesis generating study suggest that background
exposure to PCBs and p,p'-DDE early in life modulate
immune system development. Strong correlations
between mono- and di-ortho PCBs (including CB-153),
and p,p'-DDE exposures make it difficult to identify the
most important contributor to the suggested immu-
nomodulation, and to separate effects due to pre- and
postnatal exposure. Our findings may have consequences
for the health development during childhood, since respi-
ratory infections early in life may be risk factors for
asthma and middle ear infections.
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